News about Global Pharma

Astellas Gets EU Approval for VYLOY in Combination with Chemotherapy

Astellas Pharma Inc. has announced that the European Commission (EC) has approved VYLOY (zolbetuximab) in combination with fluoropyrimidine- and platinum-containing chemotherapy.

Global Pharma | 23/09/2024 | By Aishwarya |  788

Alkem Foundation Organises Walkathons to Raise Awareness about Alzheimer's Disease

Alkem Foundation collaborated with non-profit organization, HelpAge India for these walkathons, which were conducted at Girgaon Chowpatty in Mumbai, Deer Park in New Delhi, Chetla Central Park in Kolkata, Anna Nagar Tower Park in Chennai and National College Ground in Bengaluru.

Global Pharma | 21/09/2024 | By Aishwarya |  781

FDA Approves Nasal Spray Influenza Vaccine for Caregiver Administration

FluMist is approved for preventing influenza disease caused by influenza virus subtypes A and B in individuals 2 through 49 years of age.

Global Pharma | 21/09/2024 | By Aishwarya |  975

Suven Pharmaceuticals Announces Appointment of Vivek Sharma as Executive Chairman

Vivek brings tremendous CDMO and leadership expertise to Suven, acquired across his roles as CEO of Piramal Pharma Solutions and as Chairman & CEO of Adare Pharma Solutions, a technology CDMO business (2020-22).

Global Pharma | 21/09/2024 | By Aishwarya |  874

AbbVie Gets Positive CHMP Opinion for Mirvetuximab Soravtansine

AbbVie has announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing authorization of mirvetuximab soravtansine (ELAHERE).

Global Pharma | 21/09/2024 | By Aishwarya |  620

Lupin Gets FDA Approval for Bumetanide Injection

Bumetanide Injection USP, 1 mg/4 mL (0.25 mg/mL) Single-Dose Vials and 2.5 mg/10 mL (0.25 mg/mL) Multiple-Dose Vials are indicated for the treatment of edema associated with congestive heart failure, hepatic and renal disease, including the nephrotic syndrome.

Global Pharma | 20/09/2024 | By Aishwarya |  743

Lifecore Biomedical's Isolator Filler Now GMP-Ready and Operational

Lifecore is now positioned to offer existing and future customers the speed and aseptic isolation benefits of this state-of-the-art technology for fill/finish services for prefilled syringes, vials, and cartridges.

Global Pharma | 20/09/2024 | By Aishwarya |  430

Aurobindo to Fully Acquire GLS Pharma for INR 22.5 Crore

The company entered into a binding agreement with GLS Pharma Ltd. and its promoters for the acquisition of the remaining 5,90,361 equity shares of INR 10 each amounting to a 49 percent stake for a purchase consideration of INR 22.5 crore.

Global Pharma | 19/09/2024 | By Aishwarya |  852

Seran Bioscience Announces USD 200 Million Strategic Growth Transaction

The new facility will be completed in 2026 and will support oral, pulmonary, and nasal delivery modalities with commercial-scale particle engineering solutions, including spray drying, hot melt extrusion, nano-milling, and fluid-bed manufacturing, as well as comprehensive finished dose capabilities.

Global Pharma | 18/09/2024 | By Aishwarya |  636

Sanofi Begins Shipping BEYFORTUS in US

Sanofi has started shipping BEYFORTUS (nirsevimab-alip) 50mg and 100mg Injection doses in the US to private healthcare providers and to the Centers for Disease Control and Prevention for its vaccines for children program.

Global Pharma | 18/09/2024 | By Aishwarya |  517